Overview and Scope
Biopharmaceutical third-party logistics refers to a partner or service that helps in the provision of logistics services by external entities to pharmaceutical companies. These companies delegate their transportation needs to third-party providers to minimize costs, and the absence of in-house capabilities is a significant factor driving the expansion of transportation outsourcing.
Sizing and Forecast
The biopharmaceutical third-party logistics market size has grown strongly in recent years. It will grow from $131.23 billion in 2023 to $140.68 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to globalization of pharma supply chains, stringent regulatory requirements, rise in biopharmaceuticals, focus on cold chain logistics.
The biopharmaceutical third-party logistics market size is expected to see strong growth in the next few years. It will grow to $184.35 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to personalized medicine growth, biologics and biosimilars expansion, supply chain digitalization, regulatory compliance complexity, covid-19 impact. Major trends in the forecast period include on-demand logistics solutions, sustainability in logistics, last-mile delivery solutions, pharma serialization and traceability, autonomous logistics.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report
Segmentation & Regional Insights
The biopharmaceutical third-party logistics market covered in this report is segmented –
1) By Supply Chain: Cold Chain, Non-Cold Chain
2) By Service: Transportation, Warehousing And Storage, Other Services
3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users
North America was the largest region in the biopharmaceutical third party logistics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12616&type=smp
Major Driver Impacting Market Growth
The rising trend of outsourcing logistics is expected to drive the growth of the biopharmaceutical third-party logistics market. Outsourcing logistics involves engaging a third party to handle all or a portion of a company’s logistical activities. Outsourcing logistics is used in biopharmaceutical third-party logistics for outsourcing cryogenic supply chain management to logistics partners. For instance, in December 2021, according to the survey conducted by Gartner Inc., a US-based provider of technological research and consulting, in 2021, out of 298 supply chain professionals in the US around 66% of logistics leaders augmented their budget allocated to logistics outsourcing, and a projected 74% foresee a further increase within the next two years. Therefore, the rising trend of outsourcing logistics is expected to propel the growth of the biopharmaceutical third-party logistics market.
Key Industry Players
Major companies operating in the biopharmaceutical third-party logistics market report are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, Catalent Inc., Agility Logistics, Almac Group, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics, PCI Pharma Services
The biopharmaceutical third-party logistics market report table of contents includes:
1. Executive Summary
2. Biopharmaceutical Third-Party Logistics Market Characteristics
3. Biopharmaceutical Third-Party Logistics Market Trends And Strategies
4. Biopharmaceutical Third-Party Logistics Market – Macro Economic Scenario
5. Global Biopharmaceutical Third-Party Logistics Market Size and Growth
…
32. Global Biopharmaceutical Third-Party Logistics Market Competitive Benchmarking
33. Global Biopharmaceutical Third-Party Logistics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Biopharmaceutical Third-Party Logistics Market
35. Biopharmaceutical Third-Party Logistics Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
